$169/mo
Tirzepatide
Weekly and dual-action. Care, coaching and shipping included.
Get startedHome / Tirzepatide brand names
Two brand names. One maker.
What is the brand name of tirzepatide?
Tirzepatide is sold under two brand names, both made by Eli Lilly: Zepbound, for weight loss and obstructive sleep apnea, and Mounjaro, for type 2 diabetes. There’s no generic. Compounded tirzepatide isn’t a brand or a generic, and at NexLife it’s $169 a month at every dose, matched if you pay less†.
- Zepbound: weight loss and sleep apnea
- Mounjaro: type 2 diabetes
- Generic: none in the U.S.
Published by NexLifeLegitScript-certifiedUpdated October 9, 2026Medically reviewed by the NexLife clinical team, led by Adam Kennah, MD (NPI 1144260043)
Tirzepatide brand names
- Brand names
- Zepbound and Mounjaro
- Made by
- Eli Lilly and Company
- Zepbound is for
- Weight management, and sleep apnea in adults with obesity
- Mounjaro is for
- Type 2 diabetes
- Generic
- None approved in the U.S.
- At NexLife
- $169 a month, compounded, at every dose
Not sure which one you were prescribed? Call or text (949) 818-8000.
Check my eligibility, $169/mo
4.8 out of 5 on Trustpilot · LegitScript certified
Brand names
Zepbound and Mounjaro, side by side
| Zepbound | Mounjaro | |
|---|---|---|
| FDA-approved for | Chronic weight management, and moderate to severe obstructive sleep apnea in adults with obesity | Type 2 diabetes, with diet and exercise |
| Made by | Eli Lilly | Eli Lilly |
| Doses | 2.5 mg to 15 mg, once a week | 2.5 mg to 15 mg, once a week |
| How it comes | Single-dose pens, a 4-dose KwikPen and single-dose vials | Pens |
Prices checked October 7–8, 2026.
Two brands
Are Zepbound and Mounjaro the same?
Not quite. Both are Eli Lilly’s brands of tirzepatide, taken as weekly injections with matching dose strengths. What differs is the approval: Zepbound is approved for weight management and sleep apnea, Mounjaro for type 2 diabetes. That’s why insurers often cover one and not the other.
Brand name or not, you deserve a clear price.
Zepbound and Mounjaro are the brand names. Here’s what a flat price looks like next to them.
- Brand prices climb. Zepbound self-pay runs $299 to $449 a month by dose.
- Coverage varies. Insurers often treat Zepbound and Mounjaro differently.
- Generics don’t exist. No generic tirzepatide is FDA-approved.
Not a brand. A program, at one price.
- $169 at every dose. Compounded tirzepatide, all in, with no membership.
- A provider who knows your history. Reviews it before anything is prescribed, and follows your dose.
- Price Match Guarantee.† Paying less with another licensed provider? We match your regular monthly price.
Real people, real answers. Not sure which tirzepatide you were prescribed? Ask us. Call or text (949) 818-8000, 24/7.
Check my eligibility, $169/mo
Generic
Is there a generic tirzepatide?
No. There’s no FDA-approved generic tirzepatide. Compounded tirzepatide isn’t a generic: a state-licensed pharmacy prepares it for one patient’s prescription, and it isn’t FDA-approved. And Foundayo (orforglipron), Lilly’s GLP-1 pill approved in 2026, is a different medicine, not tirzepatide.
Your options
Four ways to get tirzepatide
Zepbound with insurance
If your plan covers it, you pay your copay, usually after prior authorization.
Zepbound, self-pay
$299 to $449 a month at LillyDirect, medication only.
Zepbound through a telehealth program
$448 to $598 a month at Ro, membership included.
Compounded tirzepatide at NexLife
$169 a month at every dose, with your provider, nutrition plan and 24/7 support. Not FDA-approved.
Two medications.
One flat price each.
Both are prepared by state-licensed 503A partner pharmacies and shipped free. Your provider helps you decide which one fits.
$139/mo
Semaglutide
Weekly GLP-1. Care, coaching and shipping included.
Get startedWhat’s inside every plan
- Tirzepatide: compounded, acts on two hormone pathways (GIP and GLP-1), taken once a week
- Semaglutide: compounded, acts on the GLP-1 pathway, taken once a week
- Prepared by state-licensed 503A partner pharmacies
- A licensed provider who reviews your history and follows your dose
- A personalized nutrition plan and a 1:1 coaching call
- Free expedited shipping; orders usually ship within 1 to 2 business days
- 24/7 support from real people, plus physician access during clinical hours
- HSA and FSA cards accepted, and Klarna or Afterpay at checkout
- Prefer no injections? Ask about the sublingual tablet, at its own flat price
Prescription required. Compounded medications are not FDA-approved. On 12-month plans: $139 a month for tirzepatide, $119 for semaglutide, still the same at every dose. Prices checked October 7–8, 2026.
Your dose goes up.
Your price doesn’t.
No membership, no dose surcharges, no surprises. One flat, all-inclusive monthly price at every dose.
| Month one | Month two | Month three | Every month after | |
|---|---|---|---|---|
| Tirzepatide | $169 | $169 | $169 | $169 |
| Semaglutide | $139 | $139 | $139 | $139 |
Paying less somewhere else? Send us a receipt from another licensed U.S. telehealth provider and we’ll match your regular monthly price. See the terms
Month-to-month plan, all-inclusive. Longer plans cost less and stay flat. Tirzepatide is $159, $149 and $139 a month on 3-, 6- and 12-month plans. Semaglutide is $132, $125 and $119.
What would you pay with NexLife?
Tap where you are now. We’ll show your NexLife price next to it, or tell you we’ll match it.
Pick one above to see your price.
Not today?
Prices from each provider, checked October 7–8, 2026. Brand-name and compounded medications are different products; compounded medications are not FDA-approved. †Price Match Guarantee terms apply.
The NexLife Price Match Guarantee
Keep your price.
Upgrade your care.
Already on compounded tirzepatide or semaglutide? Bring your price to NexLife. If you pay less with another licensed U.S. telehealth provider, we match your regular monthly price for as long as your plan stays active.† You keep your price, and you gain a provider who follows your dose, a personal nutrition plan, a 1:1 coaching call and real people who answer 24/7.
- 1Send a receipt from the last 60 days
- 2A NexLife provider reviews your prescription
- 3Pay your matched price, at every dose
Locked while your plan is activeSame price at every doseNo membership fee
†NexLife Price Match Guarantee: for new members switching from a licensed U.S. telehealth provider with an active prescription for compounded tirzepatide or semaglutide. Send a receipt from the last 60 days and we match your regular all-in monthly price on the month-to-month plan, for the same medication (medication plus required fees; not first-month offers, coupons or prepaid multi-month rates), for as long as your plan stays active. A NexLife provider must determine that treatment is right for you. Not open to people with Medicare, Medicaid or TRICARE coverage. Full terms.
Tirzepatide brand names: your questions
What is the brand name for tirzepatide?
Tirzepatide has two brand names, both from Eli Lilly: Zepbound, approved for weight management and for sleep apnea in adults with obesity, and Mounjaro, approved for type 2 diabetes.
Is Mounjaro the same as Zepbound?
Not exactly. Both are Eli Lilly’s brands of tirzepatide, with matching dose strengths, but each is FDA-approved for different uses: Mounjaro for type 2 diabetes, Zepbound for weight management and sleep apnea.
Is there a generic tirzepatide?
No. No generic tirzepatide is FDA-approved in the U.S. Compounded tirzepatide isn’t a generic; it’s prepared for one patient’s prescription and isn’t FDA-approved.
Who makes tirzepatide?
Eli Lilly and Company makes both brand-name versions, Zepbound and Mounjaro.
Can I get Mounjaro for weight loss?
Mounjaro is FDA-approved for type 2 diabetes. For weight management, the FDA-approved tirzepatide is Zepbound. Your provider decides what fits your health.
How much is brand-name tirzepatide without insurance?
Zepbound is $299 at 2.5 mg, $399 at 5 mg and $449 a month from 7.5 mg at LillyDirect’s self-pay prices. Compounded tirzepatide at NexLife is $169 a month at every dose, all in.
Important safety information
Compounded tirzepatide and semaglutide are not FDA-approved, and the FDA hasn’t reviewed them for safety, effectiveness or quality. Both medicines may cause thyroid tumors, including cancer: don’t use either if you or a family member has had medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).
Read the full safety information
In studies with rodents, both medicines caused thyroid tumors; it isn’t known whether they cause them in people. Tell your provider if you notice a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath.
Serious side effects can include inflammation of the pancreas (pancreatitis), gallbladder problems, low blood sugar (especially with insulin or sulfonylureas), kidney problems from dehydration, severe stomach problems, serious allergic reactions, vision changes in people with type 2 diabetes, and depression or thoughts of suicide. Tell your care team before any surgery or procedure that uses anesthesia or deep sedation. Don’t combine either medicine with other GLP-1 medicines.
Tirzepatide can make birth control pills less effective: use another method for 4 weeks after you start and after each dose increase. Semaglutide should be stopped at least 2 months before a planned pregnancy. Tell your provider if you’re pregnant, planning to be, or breastfeeding.
This is a summary, not the complete safety information. Read the full Prescribing Information for FDA-approved tirzepatide (Zepbound) and semaglutide (Wegovy), and talk with your provider. You can report side effects to the FDA at 1-800-FDA-1088 or fda.gov/medwatch.
Who checked this page
Adam Kennah, MDMedical Director, NexLife · Board-certified in emergency medicine · NPI 1144260043
Leads the NexLife clinical team, which medically reviewed this page on October 8, 2026.
NexLife editorial teamResearch and pricing
the Zepbound and Mounjaro labels, LillyDirect’s self-pay prices and the FDA approval of Foundayo
- Every fact, sourced. Each price and rule links to the page it comes from.
- How we make money. NexLife is a telehealth provider. We earn revenue when people join NexLife.
- Corrections, fast. See something wrong or out of date? Email care@nexlife.us and we’ll fix it.
Paying less elsewhere? We match it.
Prefer one flat price? $169 at every dose.
About 3 minutes online. A licensed provider decides if tirzepatide is right for you.
- 1Tell us about you
A short online health assessment, about 3 minutes.
- 2A licensed provider reviews it
You’re prescribed only if treatment is right for you.
- 3We ship it, then stay with you
Our partner pharmacy usually ships within 1 to 2 business days. Free shipping, 24/7 support.
Sources
- Eli Lilly and Company. Zepbound (tirzepatide) prescribing information.
- Eli Lilly and Company. Mounjaro (tirzepatide) prescribing information.
- Eli Lilly and Company. Zepbound through LillyDirect.
- AJMC. FDA approves monthly KwikPen option for tirzepatide in chronic weight management (February 23, 2026).
- Eli Lilly and Company. FDA approves Lilly’s Foundayo (orforglipron), news release (April 1, 2026).
- Ro. Weight loss pricing (Zepbound and Wegovy self-pay prices).
- U.S. Food and Drug Administration. FDA’s concerns with unapproved GLP-1 drugs used for weight loss.
- NexLife. Compounded tirzepatide plans.
- Novo Nordisk. Wegovy (semaglutide) prescribing information.
- LegitScript. Certification lookup for nexlife.us.
- NexLife. Compounded semaglutide plans.